Gilles Salles is a Professor of Medicine at the University of Lyon, France. He heads the Department of Hematology at Lyon-Sud University hospital, Lyon, France, and the “Clinical and Experimental Model of Lymphomagenesis” research team of the INSERM Cancer Research Center of Lyon. He is the Chairman of CALYM, the lymphoma-devoted Carnot insitute, the President of the Lymphoma Study Association (LYSA), a wordlwide renowned cooperative group in the lymphoma field, and the President of the Lymphoma Academic Resaerch Organisation (LYSARC), a premier lymphoma academic clinical research organization. He is in charge of clinical research within the executive board of Hospices Civils de Lyon. He is particularly interested in the clinical and biological study of malignant lymphomas with emphasis on the description and validation of prognostic factors as well as clinical trials in indolent lymphomas. A Coordinator or Co-Investigator in many clinical trials and studies, Gilles Salles is the author of more than 300 articles in international peer-reviewed journals including The Lancet, New England Journal of Medicine, Journal of Clinical Oncology and Blood.